GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Quantum BioPharma Ltd (NAS:QNTM) » Definitions » Future Policy Benefits

QNTM (Quantum BioPharma) Future Policy Benefits


View and export this data going back to 2018. Start your Free Trial

What is Quantum BioPharma Future Policy Benefits?

Future Policy Benefits only applies to insurance companies.


Quantum BioPharma Business Description

Traded in Other Exchanges
Address
55 University Avenue, Suite 1003, Toronto, ON, CAN, M5J 2H7
Quantum BioPharma Ltd formerly FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative, and inflammatory disorders. Along with its subsidiaries, the group is focused on pharmaceutical research and development of its compound, FSD201, an ultra-micronized PEA, for the treatment of inflammatory diseases; Lucid-Psych is used in the treatment of mental health disorders and Lucid-MS is used in the treatment of neurodegenerative disorders. The company operates in two segments: Biopharmaceutical and Strategic Investments.